Your browser doesn't support javascript.
loading
Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial.
Kuiper, Rowan; Zweegman, Sonja; van Duin, Mark; van Vliet, Martin H; van Beers, Erik H; Dumee, Belinda; Vermeulen, Michael; Koenders, Jasper; van der Holt, Bronno; Visser-Wisselaar, Heleen; Hansson, Markus; van der Velden, Annette W G; Beverloo, H Berna; Stevens-Kroef, Marian; Levin, Mark-David; Broijl, Annemiek; Waage, Anders; Sonneveld, Pieter.
Afiliação
  • Kuiper R; Department of Hematology, Erasmus Medical Center, Cancer Institute, Rotterdam, The Netherlands.
  • Zweegman S; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • van Duin M; Department of Hematology, Erasmus Medical Center, Cancer Institute, Rotterdam, The Netherlands.
  • van Vliet MH; SkylineDx, Rotterdam, The Netherlands.
  • van Beers EH; SkylineDx, Rotterdam, The Netherlands.
  • Dumee B; SkylineDx, Rotterdam, The Netherlands.
  • Vermeulen M; Department of Hematology, Erasmus Medical Center, Cancer Institute, Rotterdam, The Netherlands.
  • Koenders J; Department of Hematology, Erasmus Medical Center, Cancer Institute, Rotterdam, The Netherlands.
  • van der Holt B; HOVON Data Center, Department of Hematology, Erasmus Medical Center, Cancer Institute, Rotterdam, The Netherlands.
  • Visser-Wisselaar H; HOVON Data Center, Department of Hematology, Erasmus Medical Center, Cancer Institute, Rotterdam, The Netherlands.
  • Hansson M; Department of Hematology and Oncology, Skåne University Hospital, Lund, Sweden.
  • van der Velden AWG; Department of Hematology, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Beverloo HB; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands.
  • Stevens-Kroef M; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Levin MD; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Broijl A; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands; and.
  • Waage A; Department of Hematology, Erasmus Medical Center, Cancer Institute, Rotterdam, The Netherlands.
  • Sonneveld P; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Blood Adv ; 4(24): 6298-6309, 2020 12 22.
Article em En | MEDLINE | ID: mdl-33351127
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda